(Date:11/25/2009)...,, WASHINGTON,Nov.25/PRNewswire-USNewswire/--/E...ingandpresssyndication,introducesitsnewesthealth-r...ts:H1N1NewsToday( http://h1n1.einnews.com ). ,,...eFluepidemicfromgovernments,newsoutletsandresearch...eliverthelatestnewsontheglobaloutbreakwithreportsf...
(Date:11/25/2009)...,, -AgreementProvidesFinancialFlexibility,Allow...AVAL,Quebec,Nov.25/PRNewswire-FirstCall/-Labopharm...redintoastandbyequitydistributionagreement(SEDA)wi...isors,LLC.Underthetermsoftheagreement,YAhascommitt...eeyears,atLabopharm,sdiscretion,throughthepurchase...
(Date:11/25/2009)...,, WOODCLIFFLAKE,N.J.,Nov.25/PRNewswire-FirstCa...dayannouncedtheresultsofits"ModifiedDutchAuction"t...o$65,000,000aggregateprincipalamount,oruptoapproxi...edConvertibleNotesdue2010. ,, Basedonthecountby...sitaryforthetenderoffer,$30,805,000aggregateprinci...
(Date:11/25/2009)...Tackling climate change by reducing carbon dioxide...rect health benefits in addition to reducing the r...untries, according to a series of six papers appea... The Lancet . , Two University of California, Be...fessor of global environmental health, and Michael...
(Date:11/25/2009)...nks to stroke, cardiovascular disease may make a c... , WEDNESDAY, Nov. 25 (HealthDay News) --...at greater risk of high blood pressure. Now there,...so translates to significantly greater risk of car...lished in the Nov. 25 online edition of BMJ foun...
Breaking Medicine News(10 mins):Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 2Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 3Health News:Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 3... Mayo Clinic recently launched a ne...rmation site, MayoClinic.com. The updated site has...er,s experience. , Roches... The updated site has many new features and functi...
...N, China, March 27 /PRNewswire-Asia-FirstCall/ -- ...l" or "the Company") (Nasdaq: CSKI ), a,leading ...over-the-counter,drugs in the People,s Republic of... its fourth quarter and fiscal year 2008 financial...
..., March 26 Spring is here, so the Hispanic "got,m... raise awareness of the,important role of the "sun...ity to make our own vitamin D when the,ultraviolet...demic. The prudent use of sunscreen, sun-blocking ...
... are concentrating in areas with high doctor/patie... 26 (HealthDay News) -- Certain rural and urban ar...f access to surgical care, especially for underse...trend that could lead to shortages in some local a...
...March 26 Today, in Roach v. Stouffer , the Eight...icials acted unconstitutionally when they denied a...because of its pro-life viewpoint. The court also...issouri are using ,Choose Life, license plates to ...
...archers from NYU School of Medicine have been name...ical Institute (HHMI). The honorees, Iannis Aifant...ector of the Cancer Stem Cell Program at the NYU C...op scientists being honored by HHMI under this new...
Other Medicine News:Health News:MayoClinic.com Releases New Design 2Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth and Fiscal Year 2008 Results 2Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 2Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 3Health News:Midwest and Northeast May Face Surgeon Shortage 2Health News:Americans United for Life Applauds Ruling Directing Missouri to Issue 'Choose Life' Plate 2Health News:Two NYU Scientists Named Howard Hughes Medical Institute's early career scientists 2Health News:Two NYU Scientists Named Howard Hughes Medical Institute's early career scientists 3(Date:11/24/2009)...e/--Inadditiontofamily,friendsandhealth,cancersurv...anksgivinggratitudelist. ,, "Theyheardthefactsa...Monday,sverdictstotaling$103millionindamagesagains...womennationwidewhohavesuedWyethandPfizerpharmaceut...mpro.Wisneskiandtheothervictimsofhormonetherapyhav...
(Date:11/24/2009)...re/--PharmaceuticalInstitute,aleadingproviderofspe...otechindustry,todayannouncedthelaunchofanewe-cours...tplace e-courseisthenewestadditiontothecompany,s M...eriesofe-coursesdesignedtofillthecriticalneedforba...professionals. ,, Thenewthreemodule HospitalMar...
(Date:11/24/2009)...-USNewswire/--America,spharmaceuticalresearchandbi...estotreatorpreventHIV/AIDSandrelatedconditions,acc...ResearchandManufacturersofAmerica(PhRMA).December1...renesscampaignthatoriginatedatthe1988WorldSummitof..., "Wearegreatlyencouragedbythesecriticallyimport...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Trapeze Networks Announces Trapeze Medical Bringing Medical Grade Mobility to Healthcare Market 58848 1Trapeze Networks Announces Trapeze Medical Bringing Medical Grade Mobility to Healthcare Market 58848 2ICFH Elects New Board Member Whilly Bermudez 58846 1ICFH Elects New Board Member Whilly Bermudez 58846 2New Government Research Finds One in Every 100 Children Has Autism of Whom Nearly 40 25 Are Recovered 58844 1New Government Research Finds One in Every 100 Children Has Autism of Whom Nearly 40 25 Are Recovered 58844 2... with the Gynecologic Oncology Group -, BRISBANE,...ced it has expanded its clinical trials program th...y of its lead product candidate,BSI-201. The trial...ase,(PARP) inhibitor in the company,s DNA repair p...oma or malignant mixed mullerian tumors., This mu...
... May 28 NicOx S.A.,(Euronext Paris: COX) today an...e third pivotal phase 3 clinical trial for naproxc...the 303 study). 810 patients have been,randomized ...e in this,study, which is the final phase 3 trial ...of naproxcinod. The objective of this study is to ...
Other Medicine Technology:BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer 2NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study 2NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study 3NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study 4Quickert Grooved Director
Storz Pigtail Probe
Novus 2000 argon laser
Meridian Microruptor V Nd YAG Laser
Medicine Products: